Yale Scientists Win NIH Awards for Pioneering Work
Yale School of Medicine’s Valentina Greco and Marina R. Picciotto are among the 11 recipients of the National Institutes of Health’s Pioneer Award, which recognizes scientists who have a history of creative research and who show promise in originating “pioneering approaches to major challenges.” Greco and Picciotto will each receive $3.5 million dollars of funding over the course of five years. In addition, four young Yale scientists will receive the NIH’s Innovator Award.
Yale Investigators Receive NIH HEAL Grants to Study Solutions to the Opioid Crisis
Yale researchers representing a range of disciplines have been awarded grants through the National Institutes of Health (NIH) Helping to End Addiction Long-term Initiative (HEAL). This national effort provides $945 million in total funding to support a variety of research projects that tackle the opioid addiction and overdose crisis.
Yale Investigators' Lead Grant Awarded as Part of the NIH HEAL Initiative on Opioids
Dr. Gail D’Onofrio, Professor of Emergency Medicine and Public Health and Dr. David Fiellin, Professor of Medicine, Emergency Medicine and Public Health are lead investigators in a $25.5 Million study being conducted by the National Drug Abuse Treatment Clinical Trials Network’s New England Consortium Node.
Better Science, Better Lives: Women's Health Research at Yale is Working for You
Across the country, it’s becoming clearer every day: We must study the health of women. We must study the influence of sex-and-gender differences on health. And it’s time for all aspects of medical research and practice to embrace this change.
New Initiative Will Fund Innovative Solutions in Health Care
The Yale Institute for Global Health (YIGH) has partnered with The CoWrks Foundry and the RMZ Foundation to launch the Sustainable Health Initiative (SHI). SHI will build upon technology and local ingenuity by funding innovative start-ups to create social, health, and environmental impacts.
Breaking it Down: How the Chemistry of Digestion is Uncovering Sex-Specific Causes of Colon Cancer
A new technology called metabolomics allows researchers to explore the small chemicals formed and used during digestion as a window into the formation of diseases such as colon cancer, seeking early warning signs and potent tactics for prevention.
Twenty years and counting for Women's Health Research at Yale
Women’s Health Research at Yale (WHRY), a self-supporting center within Yale School of Medicine, will celebrate its 20th anniversary in February. With data developed through $5 million in WHRY grants to date, Yale scientists have gone on to secure $95 million in external grants to further their research into women’s health.
YCCI Beginning a Second Decade of Support
Although it is hard to believe, the Yale Center for Clinical Investigation (YCCI) is now in its second decade providing training resources and support for Yale’s clinical and translational investigators. With the second renewal of the Clinical and Translational Science Award (CTSA), YCCI is well poised to continue supporting innovative science to improve the health of patients everywhere.
The Risk of Remaining Silent: Addressing the Current Threats to Women's Health
The Affordable Care Act (ACA) has provided a major impetus to improving the health of women throughout the United States. However, many of these benefits and the reimbursements for services to care for women's health, as well as grant funding not specific to the ACA, are at risk of losing federal support.
Yale launches five-year study of origins of autism
Yale researchers will study the development of functional brain connectivity during late pregnancy to early adolescence thanks to a five-year, $12.4 million grant from Autism Centers of Excellence Program, part of efforts by the National Institutes of Health to understand the origins of autism spectrum disorders (ASD).
Scientist or Entrepreneur? Blavatnik Fund Lets Yale Researchers Be Both
Turning a discovery into a life-saving commercial product requires funding at every stage — proof-of-concept, animal tests, clinical trials. And the initial phase — the one between discovery and proof of concept — is often the hardest for faculty to overcome.
Sustainable Health Initiative: Accelerator Applications Now Open
Current Yale students, alumni, fellows, trainees, and faculty members are encouraged to apply! Sustainable Health Initiative provides a unique opportunity for early to mid-stage ventures to participate in a global health business accelerator. Selected startups receive up to $70,000 USD in seed funding, access to industry and faculty mentors, and the opportunity to learn in an international context.